Articles published by Comera Life Sciences



Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
April 03, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA


Comera Life Sciences to Present at 22nd Annual PepTalk Conference
January 12, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA


Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules
January 04, 2023
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA

Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
November 17, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA

Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights
November 10, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA


Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study
October 18, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA

Comera Life Sciences Expands Woburn Operations
October 04, 2022
From Comera Life Sciences
Via GlobeNewswire
Tickers
CMRA


ReForm Biologics Changes Name to Comera Life Sciences
January 27, 2022
From Comera Life Sciences
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.